Stock 688276 CHANGCHUN BCHT BIOTECHNOLOGY CO.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Changchun BCHT Biotechnology Co.

Equities

688276

CNE100005XY6

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 23:00:00 23/06/2024 BST 		5-day change 1st Jan Change
28.34 CNY -4.68% Intraday chart for Changchun BCHT Biotechnology Co. -8.90% -48.29%
04-24 Chinese Drug Regulator Accepts BCHT Biotechnology's Marketing Application for Influenza Nasal Spray Vaccine MT
04-19 Changchun BCHT Biotechnology Co. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Capitalization 1 28,321 28,531 22,628 11,723 - -
Enterprise Value (EV) 1 28,321 28,531 22,628 11,723 11,723 11,723
P/E ratio 111 x 157 x 45.3 x 16.6 x 12.6 x 10.5 x
Yield - 0.22% 0.27% 1.09% 1.42% 2.03%
Capitalization / Revenue 23.6 x 26.6 x 12.4 x 4.74 x 3.88 x 3.36 x
EV / Revenue 23.6 x 26.6 x 12.4 x 4.74 x 3.88 x 3.36 x
EV / EBITDA 85.5 x 108 x 34.7 x 12.6 x 10.5 x 9.08 x
EV / FCF - - - - - -
FCF Yield - - - - - -
Price to Book 8.29 x 8.02 x 5.63 x 2.49 x 2.12 x 1.79 x
Nbr of stocks (in thousands) 412,841 412,841 412,841 413,658 - -
Reference price 2 68.60 69.11 54.81 28.34 28.34 28.34
Announcement Date 18/02/22 24/02/23 23/02/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net sales 1 - 1,202 1,071 1,825 2,474 3,024 3,491
EBITDA 1 - 331.2 263.5 651.3 926.9 1,116 1,291
EBIT 1 - 261.9 187 559.3 807.6 1,058 1,271
Operating Margin - 21.79% 17.46% 30.65% 32.64% 34.99% 36.42%
Earnings before Tax (EBT) 1 - 261.6 197.8 563.8 804.2 1,063 1,277
Net income 1 418.2 243.6 181.6 501 710.5 931.3 1,120
Net margin - 20.26% 16.95% 27.46% 28.72% 30.79% 32.07%
EPS 2 1.140 0.6200 0.4400 1.210 1.712 2.256 2.712
Free Cash Flow - - - - - - -
FCF margin - - - - - - -
FCF Conversion (EBITDA) - - - - - - -
FCF Conversion (Net income) - - - - - - -
Dividend per Share 2 - - 0.1500 0.1500 0.3080 0.4030 0.5750
Announcement Date 02/04/21 18/02/22 24/02/23 23/02/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 - 507 911 775 303 642
EBITDA - - - - - -
EBIT - - - - - -
Operating Margin - - - - - -
Earnings before Tax (EBT) - - - - - -
Net income 60.57 - - - - -
Net margin - - - - - -
EPS 0.1500 - - - - -
Dividend per Share - - - - - -
Announcement Date 19/04/24 - - - - -
1CNY in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - -
Net Cash position - - - - - - -
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow - - - - - - -
ROE (net income / shareholders' equity) - 9.37% 5.21% 13.2% 15.7% 17.2% 17.3%
ROA (Net income/ Total Assets) - - 4.29% 9.94% 13.3% 14% 14.5%
Assets 1 - - 4,231 5,041 5,342 6,652 7,721
Book Value Per Share 2 - 8.280 8.620 9.740 11.40 13.40 15.80
Cash Flow per Share 2 - 0.3600 0.1000 0.6200 1.060 1.800 2.230
Capex 1 - 633 291 471 290 163 180
Capex / Sales - 52.65% 27.13% 25.79% 11.73% 5.38% 5.16%
Announcement Date 02/04/21 18/02/22 24/02/23 23/02/24 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Changchun BCHT Biotechnology Co.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
28.34 CNY
Average target price
54.56 CNY
Spread / Average Target
+92.54%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Specialty & Advanced Pharmaceuticals

1st Jan change Capi.
CHANGCHUN BCHT BIOTECHNOLOGY CO. Stock Changchun BCHT Biotechnology Co.
-48.29% 1.62B
MERCK KGAA Stock Merck KGaA
+15.93% 77.92B
KYOWA KIRIN CO. LTD. Stock Kyowa Kirin Co. Ltd.
+15.57% 8.95B
SK BIOPHARMACEUTICALS CO., LTD. Stock SK Biopharmaceuticals Co., Ltd.
-24.00% 4.31B
YUHAN CORPORATION Stock Yuhan Corporation
+13.37% 4.21B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD. Stock Shenyang Xingqi Pharmaceutical Co.,Ltd.
+31.17% 4.1B
INDIVIOR PLC Stock Indivior PLC
+9.37% 2.21B
BETTA PHARMACEUTICALS CO., LTD. Stock Betta Pharmaceuticals Co., Ltd.
-34.04% 1.96B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. Stock Shanghai Shyndec Pharmaceutical Co., Ltd.
+7.66% 1.95B
VELOXIS PHARMACEUTICALS A/S Stock Veloxis Pharmaceuticals A/S
-0.50% 1.64B
Specialty & Advanced Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 688276 Stock
  4. Financials Changchun BCHT Biotechnology Co.